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Abstract--Foot-and-mouth disease virus, Type A, is characterized by its ability to pro- 
duce small but continuous changes in its antigenic structure, especially in the presence 
of poor quality vaccines. Using the exponential relationship betxveen the volume of 
virus neutralized (y) and the amount of serum used {x), or 3' = hx", a conceptual model 
was constructed with the assumption that v' = m.P.v with v the virus population of a 
single antigenic type, P the proportion of the daughter population of that single type 
and m the multiplication of viruses at each generation. The model demonstrates both 
virus population stability with an "'effective" vaccine as well as saltation with the sud- 
den appearance of new antigenic strains in the presence of "'poor" vaccines. 
INTRODUCTION 
The ability of certain foot-and-mouth viruses {FMDV) to display antigenic drift is regularly 
observed. For example, in South America types O and A are much more frequent han 
Type C. Several serotypes of type-A FMDV emerge and disappear. It seems that small 
but continuous changes in antigenic structure of the type-A virus cause the continuous 
presence of limited outbreaks. While type C is regularly recovered in carrier studies, it 
causes only a Small number of outbreaks. Each type-C epidemic is caused by a new C 
strain, antigenically distinct from its predecessors, without the appearance of any cyclical 
pattern of emergence. Type O shows little evidence of antigenic drift[l] and some sta- 
bility[2, 3]. The practical importance of this drift was ably demonstrated in Brasil during 
1976-1977 when the field type-A strains were various and differed from the vaccine strains. 
At the time there were both poor vaccine coverage combined with the use of poor quality 
vaccines. It was held that as virus multiplied in the poorly vaccinated stock, it changed 
its antigenic haracteristics with the unvaccinated cattle serving as amplifiers of the emerg- 
ing variants and for their persistance[4]. In addition, poorly stored vaccines and the dif- 
fering thermostability of the 146S particles of the seven serotypes will affect the perform- 
ance in the field and especially the degree of primary response obtained in previously 
unvaccinated young stock[5]. A similar antigenic variation has been noted in endemic 
areas of Peru[6]. 
Support for this view is provided by Archetti and Horsfall[7], who noted that epidemics 
of influenza, especially in adults, took place against a background of immunity to prior 
infections. Thus persons with different immunization experiences who became infected 
with a single strain could produce viral populations with different antigenic patterns. This 
they confirmed elegantly in the laboratory by demonstrating that new strains did not appear 
in the absence of homologous immune serum or sera against widely different virus strains, 
but predictable new strains appeared in the presence of immune sera against different but 
related strains. Federer[8] passaged FMDV 0 SP66 in partially immune steers. After 19 
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passages it had developed into FMDV 0 Mat.66. Hyslop and Fagg[9] passaged a ,gAT-I 
strain 34 times in cattle previously vaccinated with increasing doses of an homologous 
vaccine. Virus from the last passage was significantly different from the original strain 
when measured by serum-virus neutralization and complement fixation tests. There were 
indications that a variant had appeared by the 5-7 passage because of the appearance of
clinical lesions in animals whose neutralization titres are usually considered sufficient for 
protection. Also, the virus from the 35th animal was unable to reinfect he 25th, 26th or 
the 27th animals. 
The phenotypic measurement of antigenic shift and drift in FMDV subtypes and strains 
and the relative values of r, R and D measurements in monitoring change has been ably 
reviewed by Pereira[10]. Examples of such exercises are reported by Forman[ll] and 
Anderson et al.[12]. Although these measurements are extremely valuable in field studies. 
they do not explain the nature of the antigenic variation. It would seem that antigenic and 
other changes may occur through amino acid substitutions in the viral polypeptide, VPI, 
of the FMDV capsid, either as a result of mutations or recombinations in the RNA 
genome[13-17]. 
The volume of virus neutralized by a known amount of serum is an exponential rela- 
tionship, or y = bx", with y the volume of virus neutralized and x the concentration of
serum used[18]. This exponential quantitative character of the relationship between virus 
neutralized and serum used is common to a large number of viruses, influenza, newcastle, 
western equine encephalitis and herpes, with the slope, a, being characteristic of each 
virus[19]. FMDV appears to be similar[20]. By extension, it would follow that the impact 
of a vaccine should be similar, or v, = v~o ' -e-~, with E. the efficacy, from 0 to 1.0, of the 
vaccine and v, and z,o the surviving and original virus numbers. 
The multiplication of FMDV. a necessary parameter toknow for a mathematical model, 
is indicated by Henderson[21]. who found that the peak virus titer was 10,000 times the 
original titer 12-24 h after the innoculation of tissue fragments of cattle tongue pithelium 
suspended in culture medium. Cartwright et al.[22] monitored the output at between I0= 
and 103 ID~o per 15 rain from trypsinised cattle epithelium. At the tenth to twelfth hour 
after infection, the infectivity of the culture began to decrease because of the death of virus 
producing cells and thermal inactivation of the virus. These observations present only the 
results of the virus replication and are a summation of what will have occurred in an 
unknown number of cycles in an uncertain umber of infected cells, with the logarithmic 
replication and simultaneous inactivation of viruses. 
The antigenic drift of a virus, such as FMDV, was thus mathematically modelled with 
the additional assumption, for convenience, that the appearances of daughter virus pop- 
ulations of various antigenic strains were fixed and not random. Also for convenience, 
antigenic drift and shift have been treated identically and merely differed in the degree 
of variation; the term "drift" was used to describe both conditions. The model is a radical 
simplification of what must be a most complex series of events in the field and which 
ignores the many details of the virus neutralisation process. For example, the efficacy of 
the immune response consists of two components, the intensity of the response, usually 
expressed as the antiviral titre and the amplitude or duration of the response and therefore 
the period of refractivity to reinfection. This has been reduced to a constant ability to 
kill/remove a variable proportion of viruses during each unit of time. The overall simpli- 
fication has reduced the whole process of virus replication and survival to a virus mul- 
tiplication, modified at each virus generation by the removal of some by the unspecified ac- 
tion of a "vaccine," and the distribution of surviving viral progeny mimics, if anything, only 
some aspects of what might happen in a serial series of infected animals, ignores the 
problems of animal to animal spread and does not differentiate between virus generations 
and animals. The model may be developed further, but at this stage it is not completely 
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defined. However,  the results of this hypothetical and conceptual mathematical model 
would appear to confirm, or at least mimic, Archetti and Horsfall's[7] results. 
METHOD 
The mathematical model was constructed on the following assumptions that 
v' = m.P .v ,  
where v is a virus of a single antigenic type, P the proportion of the daughter population 
of an antigenic type and m the virus multiplication at each generation, where 
(v ' )  = {v{ ,  v;_ . . . . .  v ; , ) .  
v= (v l -L , .  .,,-L-,2 -, . . . .  v~,-L").  
p = (P / , i ) .  
E is an arbitrary value from 0 to l and used to predefine the strength of the components 
of a vaccine against a virus. The strength of the various antigenic omponents of a vaccine 
are in units from 0 to 1000. The E value for each component was therefore the number 
of units as a proportion of 1000. Any vaccine can have a number of different components 
against he various viruses of antigenic types A to N. inclusive. For the sake of simplicity 
it was presumed that the transformations from one virus antigenic type to another were 
always in one direction, that is A to B. B to C, C to D and so on. and finally N to A. All 
other transformations were set at zero. although other values could have been inserted 
into the model. Also. i fv '  < 1.0, then v' = 0: this was to prevent the creeping drift of 
fractions of populations and have a minimum population below ~hich any virus would 
automatically disappear. 
The program integrating all these assumptions was written in APPLESOFT foran Apple 
I1 + computer with 48K RAM. Copies are available on request. To explore the drift away 
from and population changes of a single virus type which is being controlled by a one 
component vaccine, a simpler program was written limiting the model to only two antigens. 
A and B, with transformations only from A to B. The populations of B were therefore 
largely ignored in this instance. The full computer model was used to study the drift to 
a new antigenic type outside the control of hypothetical vaccines. All runs of either model 
started with 106 "A'"  viruses. The model stopped whenever any virus exceeded I0 ~ or 
for a maximum of 20 generations. To explore the robustness of the model, the argument 
was varied as follows: 
V, = EVo and V, = V~,-  V~. 
The terms, v i rus ,  antigen, drift or transformation, vaccine, etc., are used merely to 
make the model more friendly. It was held that the use of a more precise terminology 
would neither aid comprehension nor precision in interpreting the results. 
RESULTS 
A. Stability and threshohts 
The basic model demonstrated that there is an inherent stability such that the virus 
populations always reach a constant size, however large some of them may become (see 
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Table 1. Stable "'A" virus populations for various population mulipliers and vaccine strengths (E) with a 
starting population of 106 A viruses and P.-~A 0.999 and P.,,-B 0.001 
Vaccine strength (E) 
Multiplier 0.2 0.4 0.6 0.8 0.9 0.95 
x 10-" 9.95 × 109 99,750 2150 316 167 127 
x 103 9.95 x 10 v* 3.15 x I0": 99,833 5616 2152 1437 
x 10 ~ 9.95 x 10 ~9 9.98 x 109 4.63 x 10 ~ 99,875 27.794 16,221 
xl05 9.95 x 10 :'~ 3.15 x 10 Iz 2.15 x 10 s 1.77 x 106 358,982 183,105 
× 106 9.95 x 1029 9.98 x 10 )4 9.98 × 109 3.15 x 10" 4.63 x 106 2.07 x 10 ~' 
Tables 1 and 2). The size of this terminal and constant population is very similar, whatever 
the transition probability may be. For example, for a vaccine strength of 0.4. a population 
multiplier of 10"-. the "A'"  virus population was stable at 99,750 for the transition prob- 
abilities of PA ~ A °9'~9 and Pa ~ B °°°l, and at 100.000 "'A'" viruses for the transition 
probabilities of 0.999 999 and 0.000 001; the difference being the drift from "'A'" to " 'B" .  
"B"  will itself achieve a constant size. Unlimited exponential growth does not occur, 
while there is some vaccine constraint. 
While drift from "'A'" to 'B ' "  occurs at a probability of 0.001 for a modest multiplier, 
this drift does not occur when the probability is 0.000 001 for population multipliers up 
to and including 106 , This is to be expected in a model of this kind. If the probabilities 
of drift are very, very small in a real environment, a new daughter virus in very small 
numbers would have difficulty finding a new host and competing against the major 
population. 
For a virus to break away within the same virus type from the control of a vaccine, it 
must reach a value in excess of some arbitrary level. This level was set at 106 as this 
number was always used as the initial population size. Some minimum threshold values 
of population multipliers are given in Table 3. For example, for virus 'A ' "  to exceed a 
population size greater than lff', with a probability of drifting from "A"  to "B'"  of 0.001 
against a vaccine strength of 0.5, it must be multiplied by a factor of 1000 per generation 
at least. While it is overwhelming the anti-A vaccine, it can be producing a significant 
number of "'B'" viruses. 
B. "Competent vaccines" 
A vaccine, Vaccine I. with the following components,  anti-A 990 units, anti-B 600 units 
and anti-C 200 units, was inserted into the whole model. This model was then run with 
transformation values varying from P ......... 0.999 999 and P ..... ,,_, 0.000 001 to P ......... 
0.999 and P ..... .i-, 0.001 and virus population multipliers from × 500 to x 1,000,000. The 
Table 2. Stable "'A" virus populations for various population mulipliers and vaccine strengths (E) with a 
starting population of l06 A viruses and PA~,~, 0.999 999 and PA--B 0.000 001 
Vaccine strength (E) 
Multiplier 0.2 0.4 0.6 0.8 0.9 0.95 
xlO 2 1.0 x 10 t° 100,000 2154 316 167 127 
x 103 1.0 x lO ts 3.16 x 107 100,000 5623 2154 1438 
x lO 4 l.O x 102o 1.00 x 10 I° 4.64 x lO 6 I00,000 27,826 16,238 
xlO 5 1.0 x 1025 3.16 x IO t-' 2.15 x IO s 1.78 x lO 6 359,380 183,298 
x 106 1.0 x 1030 1.00 × I0 I~ 1.00 x 10 m 3.16 x 10" 4.64 x I06 2.07 x 106 
Note, in this series, there was no spillage from "'A'" to "B".  
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Table 3. Thresholds of virus population mulipliers and 
vaccine strength IE)* for the virus population to exceed 
106 and P.:,_~, 0.999 and P~,_~ 0.001 
Multiplier Vaccine iE) 
100 0.333 
200 0.383 
300 0.413 
400 0.434 
500 0.450 
600 0.463 
700 0.474 
800 0.484 
900 0.492 
1000 0.500 
1500 0.529 
2O00 O.550 
3000 0.579 
4000 O.600 
5000 0.616 
10.000 0.666 
100.000 0.833 
1,000.000 0.999 
* Based upon New Virus Population = Old Virus Pop- 
ulation~l - El 
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model was stopped whenever any one virus population exceeded 1,000,000 or for a max- 
imum of 20 generations; in the later instance the populations were found to be at stable 
constant values (see Table 4). 
Again we found that as long as the model was using a multiplier below the minimum 
threshold value, virus -A"  quickly stabilized at some value less than I06, When the 
probability of transformation was extremely low (0.000 001), there was only one multiplier 
value (x  870,964, which is also the minimum threshold multiplier value) when the model 
produced over  106 of any other virus before the "A"  virus; by the third generation there 
were 999,999 "A"  viruses, 207,014,093 "'B'" viruses and 207 "C"  viruses. With a mul- 
tiplier of x 870,965, there were immediately over 106 "A"  viruses before significant drift 
to other viruses could occur. If the model were left to run, a stable population would have 
eventually appeared while "A"  was constant at 106. While there is drift into the other 
viruses, "'A" always stabilized rapidly at the values shown in the various parts of Table 
4. With a higher probability of drift, i.e. 0.001, there is a much wider range of multiplier 
values until ~A"  is stable at above 106 particles; in this instance, with a probability of 
drift of 0.001, the minimum threshold was × 872, but to get '~A" itself over 1,000,000, a
multiplier of x871,836 is needed, and at this value " 'B",  "C"  and '~D", etc. are also 
growing rapidly. It can be seen by simple inspection that these stable populations of "A"  
virus are dependant on the vaccine and the multiplier but not on the drift probability; for 
example, with a multiplier of x 1000 and drift probabilities from 0.000 001 to 0.001, the 
"A'" virus population is essentially constant at 1072. The significance of this can be better 
appreciated when a less competent vaccine is used. 
C. "Incompetent vaccines" 
A vaccine, Vaccine II, with the following components,  anti-A 500 units, anti-B 600 
units, anti-C 700 units, anti-D 800 units, anti-E 900 units and anti-F 800 units, with a seed 
population of 106 "A"  viruses was inserted into the whole model. The transformation 
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Tab le  4. Mode l  resul ts  with Vacc ine  I lant i -A  990, ant i -B 600. ant i -C  200) s tar t ing with 10 ~' A v i ruses  and  the 
mode l  s topp ing  whenever  any  v i rus  exceeded 106 for  var ious  t rans format ion  probabi l i t ies  and  popu la t ion  
mult ip l iers  
(a) T rans format ions :  P . . . . . .  ~ 0.999 999 and  P~, . , .~  0.000 001. 
Popu la t ion  Virus popu la t ions  
mult ip l iers  A B C D E F 
x 500 532 
x 1000 1072 
x 10.000 10,975 
x 100.000 112,332 
× 106* 1,148.152 
w 
m 
m 
m 
(* Note ,  the thresho ld  min imum popu la t ion  mult ip l ier  was  x 870,964.)  
Popu la t ion  
mult ip l iers  
(b) T rans format ions :  P . . . . . . . .  0.999 99 and  Px~, . , . ,  0.000 01. 
V i rus  
A B C D 
x 1000 1072 - -  - -  
x 10,000 10.974 - -  - -  
x 50,000 55,774 - -  - -  
x 75,000 84.004 - -  - -  
x 80,000 89,663 - -  - -  
x 85,000 95.325 - -  - -  
x 87,500* 98,158 8,300,963 83 
x 90,000 100.991 8,673,896 87 
x 100,000 112.332 10.223.411 104.621 
m 
m 
m 
m m 
m 
m 
m 
~,* Note ,  the thresho ld  min imum popu la t ion  mult ip l ier  was  x 87.097.) 
Popu la t ion  
mult ip l iers  
(c) T rans format ions :  P.,,--..~g-t 0.9999 and p,~.,.,., 0.0001. 
V i rus  
A B C D 
× 1000 1072 - -  - -  - -  
× 5000 5449 - -  - -  - -  
× 7500 8207 - -  - -  - -  
x 8000 8759 - -  - -  __ 
x 8500 9312 - -  - -  - -  
x 8750* 9589 1,411.234 143,780 14 
x 9000 9866 1,477.306 153,177 15 
x I0.000 10.973 1.752.993 16.467.849 12,098 
m 
m 
m 
1 m 
(* Note ,  the thresho ld  min imum popu la t ion  mult ip l ier  was  × 8710.) 
Popu la t ion  
mult ip l iers  
(d) T rans format ions :  P~,_ ,  0.999 and  P .~,  . .  0.001. 
V i rus  
A B C D E 
x 500 532 - -  - -  - -  
x 750 801 - -  - -  - -  
x 800 855 - -  - -  - -  
× 850 909 - -  - -  __ 
x 875" 936 59.869 1.029.787 7028 
x 900 963 62.717 1, I 14,161 7688 
x 11300 1071 74,621 21,640.212 1,325,027 
m 
m 
6 
7 
2344 
m 
m 
1 
(* Note ,  the thresho ld  min imum popu la t ion  mult ip l ier  was  × 872.) 
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Table 6. Model results with Vaccine I1 (anti-A 500, anti-B 600, anti-C 
700. anti-D 800, anti-E 900. anti-F 800) starting with 10 6 A viruses. 
and the minimum threshold population muliplier of x 502. The model 
stopped when any virus population exceeded 106. The transformation 
probabilities were as in Table 5. P .... _~ 0.999 and P . . . . .  , 0,001 
lii) Maximum virus population at 
(i) Final status at 15' generation each generation 
A 251,511 
B 32,073 
C 7249 
D 2382 
E 1003 
F 2369 
G 219.998,989 
H 439.997 
l 220 
1 A 501,498 
2 A 355,143 
3 A 298,862 
4 A 274,160 
5 A 262,586 
6 A 256,983 
7 A 254,227 
8 A 252,859 
9 A 252,179 
10 A 251,839 
11 A 251,669 
12 A 251,585 
13 A 251.543 
14 G 438,684 
15 G 219.998,989 
probabilities were p . . . . . . .  0.999 and P ....  y i* t  0.001, and population multipliers from × 500 
to x 1050 were used. The results are shown in Tables 5 and 6. 
Below the minimum threshold multiplier the population was constant with 85% of all 
viruses being "A" .  Once the threshold is exceeded, virus "'G" will suddenly appear after 
a number of generations when the major virus has been "A" .  At the minimum threshold 
multiplier value, "G"  does not appear as the major virus until generation 14, and then it 
stopped the model in generation 15 by exceeding 106 . From this point on it will numerically 
swamp all other viruses. As the multiplier value is increased, the number of generations 
needed for " 'G" to exceed 106 become less and less until the multiplier is so large that 
"'A" immediately exceeds 106, stopping the model from further expansion. However 
"poor"  the vaccine may be, the virus populations "A"  to " 'F" essentially are stable with 
modest numbers, and the new virus is essentially invisible until it explosively declares 
itself. 
The barrier against his new virus was the anti-E with 900 units. For this the threshold 
multiplier was x 502. For 990 units, the threshold would be x 872. At this lower unit 
value, at least one "G"  virus has emerged from the "F"  population. 
D. Alternative arguments 
When the model was changed so that the surviving virus population was a simple 
proportion of the previous population (Vs = EVo), even the most modest multipliers 
caused the new population to exceed the 106 limit. 
With the third argument (Vs = Vo - Voe), the moderate virus multipliers, such as × 10-', 
were able to cause the population to exceed the 106 limit for such vaccine efficacies as 
0.95. As these multipliers are only about a tenth of what has been noted experimentally 
and the vaccine efficacy, however, arbitrary the units, was intuitively within normal ex- 
pectations, this argument was also abandoned. 
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A mathematical model of a virus multiplication is like a clockwork mouse. It might 
look like a mouse. It might run around the floor like a mouse. It might hide under furniture 
like a mouse, but it is still a poor, mechanical imitation of a real mouse. This model 
incorporates some large assumptions as to how a virus might replicate and multiply in a 
host population, and theretbre contains some extensive simplifications. The purpose of 
a conceptual model is not to predetermine what will happen where and when, which is 
the function of deterministic models, but more to elucidate some of the principles which 
might apply in a real situation. 
Firstly, for a certain set of values tbr virus multiplication, vaccine strength and drift 
probability, the daughter population of a virus will be identical with the parent population. 
At a threshold situation, which for convenience we usually obtained by manipulating the 
population multiplier, the virus population would suddenly move to encompass new vi- 
ruses and in large numbers where it would eventually reach a new equilibrium. The change 
needed in virus multiplication was extremely small to go from a stable old state to the 
new and expanded population. This small change produced a population explosion similiar 
to the sudden appearance in the field as "'new" infection. 
Secondly. until it emerged the new virus, or viruses, was invisible. The stable old 
population would numerically overlie the new viruses until uncontrolled multiplication 
causes it to emerge. Experience shows that limited laboratory facilities constrain the 
sampling and identification of field strains, with the result that a new virus in a pre- 
emergent stage is unlikely to be found and appreciated. On the other hand. there is com- 
monly a measure of cross-protection, however weak, so that the new virus will not expand 
in an uncontrolled manner but will eventually reach a new stable state, submerging the 
old viruses. 
Thirdly, it is obvious that the model pivots on the exponent used, (1 - E), from Tables 
1 and 2 it can be seen that small changes of E can result in an explosive production of 
virus if it is near the threshold value or produce only a minor change in the virus population 
if the vaccine is successfully limiting the virus population. 
The model has a number of limitations, because the environment in which a virus, or 
any other pathogen, exists is dynamic and not fixed as in this model, and because of the 
multifactorial aspects of virus replication and survival. The background serological re- 
sponse is not constant but waxes and wanes in quantity as well as quality. The successful 
multiplication of any agent is dependent on a multitude of extrinsic factors. Outside of a 
laboratory tissue culture, for example, a mutant virus can only arise within a host. Within 
a susceptible host an increase of the new population in relation to the parent population 
is dependent upon either a faster replication (such as a decreased time of replication events 
and/or increased yield per cell), or an increased chance of infecting new cells (as it absorbs 
to cells faster or has a greater chance of intercell survival). Some of these factors may 
be linked so that an antigenic difference might improve intercell survival. Unless it be- 
comes a significant fraction of the total population within that host, its chances are very 
small of successfully escaping and reaching other hosts where it can increase and replace 
a prior antigenic type. Without escape, the virus is lost when the host dies or becomes 
immune. The interhost success of the mutant depends on its ability to survive in a new 
hostile environment as it passes from one host to the next and to circumvent the barriers 
of the new host. An antigenic difference may increase its chances of successfully invading 
hosts with waning immunity, thereby increasing the population at risk to the new virus 
as compared to the parent strain. In a marginal situation, a mutant might emerge but be 
unsuccessful in surviving because of a too low density of susceptible new hosts, or it may 
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be present in trace amounts too small to provide an infective dose or to successfully 
compete with another more common virus type. 
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APPENDIX  
One of the rev iewers noted that many of the results could have been obtained without computer  
s imulat ions.  The model takes the general form 
• 
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To achieve a steady-state, 
which leads to 
and 
-~'.~ mp "' t -  E, 
:'B = mq c.~ -e '  + z,~ -E:. 
"cA = (mp)  rE '  (1) 
Z'IB -E :  - -  Z'B = --  r l lq (mp)  I E I -  I. (2) 
The values of Va in (1) are easily calculated from m. p and El. These correspond to the results 
shown in Tables 1 and 2. For the results of Table 3 we must have values of m and E~ such that 
w,  = ( raP)  I E~ > 100,000. 
The behaviour of vB depends on the solutions to Eq. (2), i.e. 
XI  - E :  - -  X = - -  C ,  
